SMT201300085B - Composti di pirrolo - Google Patents

Composti di pirrolo

Info

Publication number
SMT201300085B
SMT201300085B SM201300085T SM201300085T SMT201300085B SM T201300085 B SMT201300085 B SM T201300085B SM 201300085 T SM201300085 T SM 201300085T SM 201300085 T SM201300085 T SM 201300085T SM T201300085 B SMT201300085 B SM T201300085B
Authority
SM
San Marino
Prior art keywords
halogen
optionally substituted
group optionally
alkyl group
hydrogen atom
Prior art date
Application number
SM201300085T
Other languages
English (en)
Italian (it)
Inventor
Haruyuki Nishida
Yasuyoshi Arikawa
Ikuo Fujimori
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41508823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201300085(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of SMT201300085B publication Critical patent/SMT201300085B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SM201300085T 2008-08-27 2013-07-26 Composti di pirrolo SMT201300085B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008218851 2008-08-27
JP2008269099 2008-10-17
PCT/JP2009/065279 WO2010024451A1 (fr) 2008-08-27 2009-08-26 Composés pyrrole

Publications (1)

Publication Number Publication Date
SMT201300085B true SMT201300085B (it) 2013-09-06

Family

ID=41508823

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300085T SMT201300085B (it) 2008-08-27 2013-07-26 Composti di pirrolo

Country Status (38)

Country Link
US (3) US8969387B2 (fr)
EP (1) EP2318390B1 (fr)
JP (1) JP5638515B2 (fr)
KR (1) KR101629181B1 (fr)
CN (1) CN102197033B (fr)
AR (1) AR073136A1 (fr)
AU (1) AU2009284867B2 (fr)
BR (1) BRPI0917705A2 (fr)
CA (1) CA2735162C (fr)
CL (1) CL2011000402A1 (fr)
CO (1) CO6321166A2 (fr)
CR (1) CR20110169A (fr)
CY (1) CY1114452T1 (fr)
DK (1) DK2318390T3 (fr)
DO (1) DOP2011000061A (fr)
EA (1) EA019741B1 (fr)
EC (1) ECSP11010912A (fr)
ES (1) ES2423289T3 (fr)
GE (1) GEP20135786B (fr)
HR (1) HRP20130653T1 (fr)
IL (1) IL211335A (fr)
JO (1) JO2871B1 (fr)
MA (1) MA32647B1 (fr)
ME (1) ME01598B (fr)
MX (1) MX2011001955A (fr)
MY (1) MY152008A (fr)
NZ (1) NZ591793A (fr)
PE (2) PE20110300A1 (fr)
PL (1) PL2318390T3 (fr)
PT (1) PT2318390E (fr)
RS (1) RS52872B (fr)
SI (1) SI2318390T1 (fr)
SM (1) SMT201300085B (fr)
TW (1) TWI473798B (fr)
UA (1) UA105185C2 (fr)
UY (1) UY32074A (fr)
WO (1) WO2010024451A1 (fr)
ZA (1) ZA201101774B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20110300A1 (es) * 2008-08-27 2011-06-16 Takeda Pharmaceutical Compuestos de pirrol como inhibidores de la bomba de protones
US20110229879A1 (en) * 2010-03-19 2011-09-22 University Of Rochester Methods and compositions for nuclear staining
CN102452979B (zh) * 2010-11-03 2015-04-01 天津药明康德新药开发有限公司 5-氟-3-吡啶磺酰氯的合成方法
CN102863371B (zh) * 2011-07-06 2016-04-13 中国科学院上海有机化学研究所 氟代二氢吡咯或氟代吡咯
US10039813B2 (en) 2012-02-07 2018-08-07 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
JP6216338B2 (ja) 2012-06-27 2017-10-18 武田薬品工業株式会社 塩により安定化されたアミンおよび有機酸の液状製剤
WO2014133059A1 (fr) * 2013-02-28 2014-09-04 武田薬品工業株式会社 Procédé de production d'un composé de chlorure de sulfonyle
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
KR102084185B1 (ko) 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用
UY36547A (es) 2015-02-05 2016-06-01 Bayer Cropscience Ag Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
JP6778680B2 (ja) 2015-07-30 2020-11-04 武田薬品工業株式会社 錠剤
CN108137548A (zh) 2015-08-07 2018-06-08 拜耳作物科学股份公司 作为农药的2-(杂)芳基取代的稠合杂环衍生物
CN106430006B (zh) * 2016-08-18 2018-06-12 国网湖南省电力公司带电作业中心 配电线路移动式绝缘登高作业装置及方法
CN108203430A (zh) * 2016-12-16 2018-06-26 天地人和生物科技有限公司 一种新型可逆性质子泵抑制剂及其制备方法和用途
JP7228535B2 (ja) 2017-07-10 2023-02-24 武田薬品工業株式会社 ボノプラザン含有製剤
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN113527536B (zh) * 2020-04-21 2024-03-22 杭州德柯医疗科技有限公司 一种含氟多糖高分子化合物及其制备方法
KR20210156235A (ko) * 2020-06-17 2021-12-24 일동제약(주) 신규한 산 분비 억제제 및 이의 용도
EP4074317A1 (fr) 2021-04-14 2022-10-19 Bayer AG Dérivés de phosphore en tant que nouveaux inhibiteurs de sos1
CN113620930B (zh) * 2021-07-12 2022-08-16 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用
WO2023113474A1 (fr) * 2021-12-15 2023-06-22 일동제약(주) Nouveau sel de dérivé 1-sulfonylpyrrole, son procédé de préparation et composition pharmaceutique comprenant celui-ci
US20250084026A1 (en) * 2021-12-15 2025-03-13 Ildong Pharmaceutical Co., Ltd. Novel salt of 1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical composition comprising thereof
KR20230102353A (ko) * 2021-12-30 2023-07-07 주식회사 대웅제약 삼중음성유방암의 예방 또는 치료용 약학적 조성물
WO2026029625A1 (fr) * 2024-08-02 2026-02-05 일양약품주식회사 Dérivé de 4-cyclopropyl pyrrole et son utilisation

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66477T1 (de) 1986-08-29 1991-09-15 Pfizer 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren.
US5128366A (en) 1990-07-05 1992-07-07 Shinogi & Co., Ltd. Pyrrole derivatives
US5331006A (en) 1990-08-31 1994-07-19 Warner-Lambert Company Amino acid analogs as CCK antagonists
WO1992004025A1 (fr) 1990-08-31 1992-03-19 Warner-Lambert Company Analogues d'acides amines utilises comme antagonistes de cholecystokinine
PL170837B1 (pl) 1991-10-18 1997-01-31 Monsanto Co S rod ek g r zybobó j c zy PL PL PL PL PL PL
CN1071924A (zh) 1991-10-29 1993-05-12 纳幕尔杜邦公司 除草的三唑羧酸酰胺
JPH06135961A (ja) 1992-10-23 1994-05-17 Nippon Iyakuhin Kogyo Kk 新規ジフェニルピロリルフラン誘導体
US5286742A (en) 1992-11-03 1994-02-15 American Cyanamid Company Pyrrole thiocarboxamide insecticidal and acaricidal agents
US5480902A (en) * 1993-08-31 1996-01-02 American Cyanamid Company Thienylpyrrole fungicidal agents
JPH08119936A (ja) 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
CZ63199A3 (cs) 1996-08-28 1999-08-11 The Procter & Gamble Company Sloučeniny typu substituovaných cyklických aminů jako inhibitory metaloproteáz, způsob jejich přípravy a použití jako léčiv
CN1246847A (zh) 1996-12-23 2000-03-08 杜邦药品公司 作为Xa因子抑制剂的含氮杂芳族化合物
JPH11209344A (ja) 1998-01-26 1999-08-03 Kyowa Hakko Kogyo Co Ltd 含窒素複素環化合物
GB9817548D0 (en) 1998-08-12 1998-10-07 Novartis Ag Organic compounds
AU2825000A (en) 1999-03-10 2000-09-28 Shionogi & Co., Ltd. Medicinal compositions with (2.2.1) and (3.1.1) bicycloskeleton antagonistic to both of pgd2/txa2 receptors
TW575561B (en) 1999-03-25 2004-02-11 Hoffmann La Roche 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
AU3783100A (en) 1999-06-14 2000-12-21 Dow Agrosciences Llc Substituted triazoles, imidazoles and pyrazoles as herbicides
ATE309995T1 (de) * 1999-08-26 2005-12-15 Aventis Pharma Inc Substituierte (aminoiminomethyl oder aminomethyl) dihydrobenzofurane und benozopyrane
EP1284260A4 (fr) 2000-05-22 2004-03-31 Takeda Chemical Industries Ltd Inhibiteurs de tyrosine phosphatase
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
GB0016453D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
AU2002334733B2 (en) 2001-10-01 2006-11-23 Arena Pharmaceuticals, Inc. MCH receptors antagonists
MXPA04004464A (es) * 2001-11-08 2004-08-11 Upjohn Co Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
AU2002342909A1 (en) 2001-11-22 2003-06-10 Ciba Specialty Chemicals Holding Inc. Pyrrole synthesis
WO2003057669A1 (fr) 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Antagonistes du recepteur androgene
AU2003216274A1 (en) 2002-02-11 2003-09-04 Neurocrine Biosciences, Inc. Pyrrole derivatives as ligands of melanocortin receptors
AU2003209114A1 (en) 2002-02-14 2003-09-04 Wyeth Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
TW200306191A (en) 2002-02-22 2003-11-16 Teijin Ltd Pyrrolopyrimidine derivatives
JP4287816B2 (ja) 2002-06-13 2009-07-01 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー ピラゾールカルボキサミド殺虫剤
MXPA05001688A (es) 2002-08-12 2005-04-19 Sugen Inc 3-pirrolil-piridopirazoles y 3-pirrolil-indazoles como inhibidores de cinasa novedosos.
JP2004315511A (ja) 2003-03-31 2004-11-11 Taisho Pharmaceut Co Ltd Ｍｃｈ受容体アンタゴニスト
WO2004103968A1 (fr) 2003-05-26 2004-12-02 Aponetics Ag Sulfopyrroles
EP2336107B1 (fr) * 2004-09-30 2015-09-23 Takeda Pharmaceutical Company Limited Inhibiteurs de pompe a protons
EP1655284A1 (fr) 2004-10-26 2006-05-10 Aponetics AG 2-Phenylsulfopyrroles
EP2327692B9 (fr) 2005-08-30 2014-06-04 Takeda Pharmaceutical Company Limited Dérivés de1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl-1-H-pyrrole substitués et leur utilisation en tant qu'inhibiteurs de la sécrétion d'acide gastrique
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
EP2005957B1 (fr) 2006-03-31 2012-05-30 Takeda Pharmaceutical Company Limited Inhibiteur de secretion d'acide
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
PE20090709A1 (es) 2007-09-28 2009-07-15 Takeda Pharmaceutical Compuestos heterociclico de 5 miembros
US20090318429A1 (en) * 2008-04-28 2009-12-24 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
EA018988B1 (ru) 2008-05-16 2013-12-30 Такеда Калифорния, Инк. Активаторы глюкокиназы
PE20110300A1 (es) * 2008-08-27 2011-06-16 Takeda Pharmaceutical Compuestos de pirrol como inhibidores de la bomba de protones

Also Published As

Publication number Publication date
IL211335A (en) 2013-12-31
PT2318390E (pt) 2013-07-10
US20140031393A1 (en) 2014-01-30
PE20141174A1 (es) 2014-09-19
CY1114452T1 (el) 2016-10-05
EA019741B1 (ru) 2014-05-30
CN102197033A (zh) 2011-09-21
CO6321166A2 (es) 2011-09-20
AU2009284867A1 (en) 2010-03-04
RS52872B (sr) 2013-12-31
KR101629181B1 (ko) 2016-06-13
HK1157756A1 (en) 2012-07-06
KR20110071067A (ko) 2011-06-28
MA32647B1 (fr) 2011-09-01
UA105185C2 (uk) 2014-04-25
EP2318390A1 (fr) 2011-05-11
HRP20130653T1 (en) 2013-08-31
CR20110169A (es) 2011-05-16
CL2011000402A1 (es) 2011-07-29
CN102197033B (zh) 2014-07-16
AU2009284867A2 (en) 2011-04-21
ES2423289T3 (es) 2013-09-19
BRPI0917705A2 (pt) 2016-02-16
MX2011001955A (es) 2011-03-29
JP5638515B2 (ja) 2014-12-10
TW201010993A (en) 2010-03-16
ME01598B (me) 2014-09-20
US20110172275A1 (en) 2011-07-14
ZA201101774B (en) 2012-06-27
GEP20135786B (en) 2013-03-11
ECSP11010912A (es) 2011-04-29
JO2871B1 (en) 2015-03-15
IL211335A0 (en) 2011-04-28
JP2012501296A (ja) 2012-01-19
SI2318390T1 (sl) 2013-08-30
MY152008A (en) 2014-08-15
PL2318390T3 (pl) 2013-09-30
US20100056577A1 (en) 2010-03-04
PE20110300A1 (es) 2011-06-16
DK2318390T3 (da) 2013-07-08
US8592597B2 (en) 2013-11-26
NZ591793A (en) 2012-11-30
DOP2011000061A (es) 2011-04-15
CA2735162A1 (fr) 2010-03-04
CA2735162C (fr) 2015-06-23
EP2318390B1 (fr) 2013-05-01
US8993598B2 (en) 2015-03-31
EA201170384A1 (ru) 2011-10-31
TWI473798B (zh) 2015-02-21
UY32074A (es) 2010-03-26
AR073136A1 (es) 2010-10-13
WO2010024451A1 (fr) 2010-03-04
AU2009284867B2 (en) 2014-08-28
US8969387B2 (en) 2015-03-03

Similar Documents

Publication Publication Date Title
MY152008A (en) Pyrrole compounds
MY177250A (en) Novel nicotinamide derivative or salt thereof
SMAP201100019A (it) Composti organici.
MX2009008465A (es) Nuevas 2-aminooxazolinas como ligandos de taar1.
DK2074120T3 (da) Tropan-forbindelser
EA201170096A1 (ru) Замещенные производные пиримидона
CY1111671T1 (el) Ετεροκυκλικη ενωση
EA201290401A1 (ru) Азотсодержащее гетероциклическое соединение и сельскохозяйственный фунгицид
EA201201378A1 (ru) Определенные аминопиримидины, композиции на их основе и способы их использования
MY169179A (en) Novel piperidine compound or salt thereof
WO2008108378A3 (fr) Dérivé bicyclique d'oxomorpholine
WO2008108380A3 (fr) Composés de pyrrole
MX2010004893A (es) Compuesto heterociclico y composicion farmaceutica del mismo.
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
EA200971044A1 (ru) Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
TW201129558A (en) Piperazine compound having a pgds inhibitory effect
MY160882A (en) Biocidal composition and method
EA201100696A1 (ru) 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6
PH12013501856A1 (en) Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
UA111950C2 (uk) Гетероциклічні сполуки для лікування або профілактики розладів, викликаних зниженою нейротрансмісією серотоніну, норепінефрину або допаміну
MY185558A (en) Pyrido-oxazinone derivatives as tnap inhibitors
WO2009025265A1 (fr) Dérivé de pipérazine
WO2009057733A1 (fr) Nouveau dérivé d'indole présentant une activité anti-angiogénique
TN2011000094A1 (en) Pyrrole compounds
ECSP13012489A (es) Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones